Holen Sie sich die Stockscreener-App
31.59
4.04%
-1.30
Schlusskurs vom Vortag:
$32.89
Offen:
$32.87
24-Stunden-Volumen:
1.10M
Relative Volume:
0.61
Marktkapitalisierung:
$1.90B
Einnahmen:
$362.27M
Nettoeinkommen (Verlust:
$-85.19M
KGV:
-21.79
EPS:
-1.45
Netto-Cashflow:
$-68.71M
1W Leistung:
-7.67%
1M Leistung:
+1.58%
6M Leistung:
-19.57%
1J Leistung:
-24.08%
1-Tages-Spanne:
$30.97
$33.30
1-Wochen-Bereich:
$30.91
$34.44
52-Wochen-Spanne:
$24.07
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
31.56 | 1.99B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
564.78 | 213.17B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
214.08 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.79 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.72 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
214.00 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire
What does recent volatility data suggest for Twist Bioscience CorporationWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com
Combining machine learning predictions for Twist Bioscience CorporationWeekly Trend Summary & Safe Capital Investment Plans - newser.com
Long term hold vs stop loss in Twist Bioscience CorporationMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com
Is Twist Bioscience Corporation stock ready for breakoutJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
What insider trading reveals about Twist Bioscience Corporation stockInsider Selling & Weekly High Return Stock Opportunities - newser.com
Will Twist Bioscience Corporation bounce back from current support - newser.com
Is Twist Bioscience Corporation (0ME) stock trading at attractive multiples2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Jennison Associates LLC Has $22.75 Million Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
How sustainable is Twist Bioscience Corporation stock dividend payoutJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
Will Twist Bioscience Corporation outperform the market2025 Price Momentum & AI Based Trade Execution Alerts - newser.com
Is Twist Bioscience Corporation forming a reversal patternWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
TWST insider Form 4: 29,518 PSUs credited; holdings 128,228 - Stock Titan
TWST Form 4: 35,513 PSUs credited; 60% vest by Oct 1, 2026 - Stock Titan
TWST Form 4: CAO reports 5,633-share PSU award, vesting in 2026 - Stock Titan
Form 4: TWST CFO reports 25,000 shares; 60% vests by Oct 1, 2026 - Stock Titan
Will Twist Bioscience Corporation stock continue upward momentumJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
How Twist Bioscience Corporation stock compares to market leadersWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Will Twist Bioscience Corporation stock return to pre crisis levels - newser.com
Is Twist Bioscience Corporation stock undervalued vs historical averagesEntry Point & Safe Entry Momentum Tips - newser.com
Why Twist Bioscience Corporation (0ME) stock appeals to dividend investorsRate Hike & Daily Market Momentum Tracking - fcp.pa.gov.br
Top chart patterns to watch in Twist Bioscience Corporation2025 Stock Rankings & Consistent Profit Alerts - newser.com
Volatility clustering patterns for Twist Bioscience CorporationPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Twist Bioscience Corporation holdersDividend Hike & Safe Capital Growth Plans - newser.com
Is Twist Bioscience Corporation stock in correction or buying zoneJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18 - Markets Mojo
Is Twist Bioscience Corporation (0ME) stock prepared for digital transitionJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
Will Twist Bioscience Corporation stock beat EPS estimatesMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Twist Bioscience COO Finn sells $69k in shares By Investing.com - Investing.com Canada
Twist Bioscience COO Finn sells $69k in shares - Investing.com
Twist Bioscience Exec Sells Shares to Cover Tax Obligations - TradingView
TWST Form 4: COO sold 2,240 shares at $30.875 for tax withholding - Stock Titan
Is Twist Bioscience Corporation building a consolidation baseWatch List & Fast Moving Stock Trade Plans - newser.com
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):